Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review

被引:170
作者
Li, Bingqian [1 ]
Shao, Huili [1 ]
Gao, Lei [1 ]
Li, Huan [1 ]
Sheng, Huagang [1 ]
Zhu, Liqiao [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Coll Pharm, Daxue Rd 4655, Jinan 250355, Peoples R China
关键词
Nano-drug co-delivery system; combination therapy; natural active ingredients; chemotherapy drugs; nanocarrier; MESOPOROUS SILICA NANOPARTICLES; NANOSTRUCTURED LIPID CARRIERS; CALCIUM-CARBONATE NANOPARTICLES; HEPATOCELLULAR-CARCINOMA CELLS; ENHANCED ANTITUMOR-ACTIVITY; MULTIDRUG-RESISTANCE; IN-VITRO; LUNG-CANCER; TARGETED NANOPARTICLES; HYBRID NANOPARTICLES;
D O I
10.1080/10717544.2022.2094498
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chemotherapy drugs have been used for a long time in the treatment of cancer, but serious side effects are caused by the inability of the drug to be solely delivered to the tumor when treating cancer with chemotherapy. Natural products have attracted more and more attention due to the antitumor effect in multiple ways, abundant resources and less side effects. Therefore, the combination of natural active ingredients and chemotherapy drugs may be an effective antitumor strategy, which can inhibit the growth of tumor and multidrug resistance, reduce side effects of chemotherapy drugs. Nano-drug co-delivery system (NDCDS) can play an important role in the combination of natural active ingredients and chemotherapy drugs. This review provides a comprehensive summary of the research status and application prospect of nano-delivery strategies for the combination of natural active ingredients and chemotherapy drugs, aiming to provide a basis for the development of anti-tumor drugs.
引用
收藏
页码:2130 / 2161
页数:32
相关论文
共 268 条
[1]   Evaluation of the cytotoxic and apoptogenic effects of cinnamaldehyde on U87MG cells alone and in combination with doxorubicin [J].
Abbasi, Abbas ;
Hajialyani, Marziyeh ;
Hosseinzadeh, Leila ;
Jalilian, Fereshteh ;
Yaghmaei, Parichehr ;
Navid, Sahar Jamshidi ;
Motamed, Hajar .
RESEARCH IN PHARMACEUTICAL SCIENCES, 2020, 15 (01) :26-35
[2]   Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma [J].
Abd Elwakil, Mahmoud M. ;
Mabrouk, Moustafa T. ;
Helmy, Maged W. ;
Abdelfattah, Elsayeda-Zeinab A. ;
Khiste, Sachin K. ;
Elkhodairy, Kadria A. ;
Elzoghby, Ahmed O. .
NANOMEDICINE, 2018, 13 (16) :2015-2035
[3]   An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells [J].
Abedi, Fatemeh ;
Davaran, Soodabeh ;
Hekmati, Malak ;
Akbarzadeh, Abolfazl ;
Baradaran, Behzad ;
Moghaddam, Sevil Vaghefi .
JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)
[4]   Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis [J].
Ali, Nemat ;
Rashid, Summya ;
Nafees, Sana ;
Hasan, Syed Kazim ;
Sultana, Sarwat .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 385 (1-2) :215-223
[5]   A novel smart PEGylated gelatin nanoparticle for co-delivery of doxorubicin and betanin: A strategy for enhancing the therapeutic efficacy of chemotherapy [J].
Amjadi, Sajed ;
Hamishehkar, Hamed ;
Ghorbani, Marjan .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2019, 97 :833-841
[6]   PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance [J].
Anbazhagan, Rajeshkumar ;
Muthusamy, Ganesan ;
Krishnamoorthi, Rajakumari ;
Kumaresan, Swedha ;
Rajendra Prasad, Nagarajan ;
Lai, Juin-Yih ;
Yang, Jen-Ming ;
Tsai, Hsieh-Chih .
BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (03) :1213-1223
[7]   Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma [J].
Anwar, Doaa M. ;
Khattab, Sherine N. ;
Helmy, Maged W. ;
Kamal, Mohamed K. ;
Bekhit, Adnan A. ;
Elkhodairy, Kadria A. ;
Elzoghby, Ahmed O. .
BIOCONJUGATE CHEMISTRY, 2018, 29 (09) :3026-3041
[8]   Tumor-targeted nanomedicines for cancer theranostics [J].
Arranja, Alexandra G. ;
Pathak, Vertika ;
Lammers, Twan ;
Shi, Yang .
PHARMACOLOGICAL RESEARCH, 2017, 115 :87-95
[9]   A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells [J].
Baek, Jong-Suep ;
Cho, Cheong-Weon .
ONCOTARGET, 2017, 8 (18) :30369-30382
[10]   Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets [J].
Baghbani, Fatemeh ;
Mortarzadeh, Fathollah .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2017, 153 :132-140